AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glycocare M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Archicare Limited

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glycocare M 80mg/500mg Tablet

Diabetam 80mg/500mg tablets are classified as antidiabetic medications, a dual-drug formulation for managing type 2 diabetes in adults. This medication helps regulate blood glucose. Diabetam 80mg/500mg tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Maintain regular mealtimes and carry a quick-acting glucose source (e.g., sugary foods, fruit juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glycocare M 80mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Glycocare M 80mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glycocare M 80mg/500mg Tablet whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with a meal.

Common Side effects of Glycocare M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glycocare M 80mg/500mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glycocare M 80mg/500mg tablets with food.

How Glycocare M 80mg/500mg Tablet works:

Gliclazide and metformin, combined in Glycocare M 80mg/500mg tablets, offer dual action against diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glycocare M 80mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glycocare M 80mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where potential advantages outweigh the hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glycocare M 80mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glycocare M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glycocare M 80mg/500mg tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glycocare M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advisable. For those with mild to moderate liver disease, initiation should be at a low dose; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glycocare M 80mg/500mg Tablet :

Should you forget a Glycocare M 80mg/500mg Tablet dose, take it immediately if remembered. Near the time for your next dose, however, omit the missed tablet and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glycocare M 80mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glycocare M 80mg/500mg Tablet

Glycocare M 80mg/500mg tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Gliclazide stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and improves cellular insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Glycocare M 80mg/500mg tablets may cause common adverse reactions such as low blood sugar (hypoglycemia), altered taste perception, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially severe side effects, including lactic acidosis, are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Glycocare M 80mg/500mg Tablets may induce hypoglycemia (low blood sugar). This can manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Glycocare M 80mg/500mg Tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction to metformin. Risk is heightened in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Lactic acidosis symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Glycocare M 80mg/500mg Tablet use and seek immediate medical attention.
Glycocare M 80mg/500mg Tablet may induce vitamin B12 deficiency with prolonged administration. This is due to the medication's interference with the stomach's absorption of vitamin B12. Untreated deficiency can lead to anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. Prophylactic annual supplementation with external vitamin B12 sources has been proposed by some investigators to mitigate these risks.
Glycocare M 80mg/500mg Tablets are contraindicated in individuals with hypersensitivity to any ingredient or inactive component. The medication should also be omitted in patients exhibiting moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Glycocare M 80mg/500mg tablets is inadvisable. This combination risks dangerously low blood glucose and raises the probability of lactic acidosis.
Glycocare M 80mg/500mg tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used concurrently with a suitable diet and regular physical activity. Gliclazide stimulates pancreatic insulin secretion, reducing blood glucose. Metformin acts by decreasing hepatic glucose production and improving cellular responsiveness to insulin. This formulation is unsuitable for managing type 1 diabetes.
Glycocare M 80mg/500mg Tablets may cause common adverse reactions such as low blood sugar (hypoglycemia), taste disturbances, queasiness, abdominal discomfort, loose stools, cephalalgia, and upper respiratory infections. Rare but potentially severe side effects, including lactic acidosis, are also possible. Prolonged administration may result in vitamin B12 depletion.
Glycocare M 80mg/500mg Tablets may induce hypoglycemia (low blood sugar). Manifestations of low blood sugar can include nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carry glucose tablets, honey, or fruit juice for immediate treatment.
Glycocare M 80mg/500mg Tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This complication, also termed Metformin-associated lactic acidosis (MALA), is uncommon but associated with metformin use. To mitigate risk, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, or those consuming substantial alcohol. Lactic acidosis symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms occur, discontinue Glycocare M 80mg/500mg Tablets and seek immediate medical attention.
Glycocare M 80mg/500mg Tablet may induce vitamin B12 deficiency with prolonged administration. This is because the medication hinders the stomach's absorption of vitamin B12. Untreated deficiency can lead to anemia, neurological complications such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and impaired balance. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, is recommended by some studies.
Glycocare M 80mg/500mg Tablets are contraindicated in individuals with hypersensitivity to any ingredient or inactive component. Their use is also prohibited in patients exhibiting moderate to severe renal impairment or those with pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Glycocare M 80mg/500mg tablets is inadvisable. This combination risks dangerously low blood glucose and heightened lactic acidosis probability.
Glycocare M 80mg/500mg Ta...
49
MRP 60
18% off